MedPath

Electronic Compliance Monitoring in Opioid Substitution Treatment

Not Applicable
Completed
Conditions
Opiate Dependence
Registration Number
NCT01182402
Lead Sponsor
Kuopio University Hospital
Brief Summary

The purpose of this study is to improve unsupervised dosing of opioid substitution medications. The aim of the study is to examine whether electronic compliance monitoring provides some advantages to patients'treatment and what kind of patients especially benefit from monitoring. We would also like to know if electronic compliance monitoring can prevent the abuse/diversion of medications and how implementing this method to wider treatment facilities succeeds.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
37
Inclusion Criteria
  • opiate dependence F11.22 according to ICD-10
  • Suboxone treatment
  • the duration of substitution treatment before study at least one month
  • stable medication dose
Exclusion Criteria
  • unstable situation in life according to treatment staff's opinions

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
The effectiveness of treatment (Treatment Outcomes Profile TOP)Every two months.

Structured interview designed to measure the effectiveness and outcomes of opioid substitution treatment.

Secondary Outcome Measures
NameTimeMethod
Patients´opinions about the treatment.Once when the study phase ends (after four months).

Questionnaire designed for this study to explore patients' opinions on the compliance monitoring and it's effect on their treatment and abuse and/or diversion of medications.

Trial Locations

Locations (1)

Kuopio University Hospital

🇫🇮

Kuopio, Finland

Kuopio University Hospital
🇫🇮Kuopio, Finland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.